Thanks for reposting your baseless commentary again, but I think it’s a good idea to look beyond social media to find full-context credible sources and to consult licensed oncologists.
JAMA Oncology is a peer-reviewed medical journal that us part of the Journal of the American Medical Association (JAMA) network, which is one of the most widely respected and influential medical journal publishers globally.
Being a peer-reviewed journal means that research articles submitted to JAMA Oncology undergo a thorough evaluation process by independent experts in the field before they are accepted for publication. This process helps ensure the quality, validity, and scientific rigor of the research presented in the journal.
Researchers, healthcare professionals, and the medical community rely on publications like JAMA Oncology for up-to-date and credible information in the field of oncology.
For a reliable appraisal of the DCVax-L P3 trial, its design, and the significance of the resulting survival data, it is advisable to refer to the analyses of qualified physicians. One such analysis can be found on the JAMA Oncology website where the link to the independent peer review and supplementary materials are published. https://ceoworld.biz/2022/04/05/top-5-medical-journals-in-the-world-everyone-should-know-about/
This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated with improved survival in both newly diagnosed & recurrent glioblastoma compared with matched controls who received SOC treatment. https://t.co/Uso7Pkh1Kt
I have to say the level of your stupidity is profound. No wonder you are recruited as a minion. If you cannot read the data, your boss should be able to.
You are so wrong!; ). I am up considerably because I cost averaged down big time back between $.17 and $.22 and then after the double bottom was called here on this forum. You on the other hand only have the pennies earned from constant repetition. At least you gave up on trying to be credible with the science and went back to the script where repetition and annoyance levels based on tone of response seem to be linked to your compensation ; ). By the way, thanks for all the attention lately. Must be the end of the line for you all. Think you all can get it back to the $.58 trend line one more time?; ). Best wishes.